linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Brooks Laboratories Ltd.
 
Source DateBoard Meeting DateDetails
29 Jan 202606 Feb 2026 Quarterly Results
07 Nov 202514 Nov 2025 Quarterly Results
07 Aug 202513 Aug 2025 Quarterly Results
23 May 202528 May 2025 Audited Results
10 Feb 202513 Feb 2025 Quarterly Results
09 Dec 202411 Dec 2024 Preferential Issue of shares Inter-alia, to consider and approve the following: 1. To consider and approve the proposal for raising funds through the issuance of securities (Equity Shares) by way of a preferential issue. This includes finalizing the number of securities, issue price, and the aggregate amount to be raised (Size of Issue) Object of the Issue, in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018. The proposal will be subject to requisite approvals. 2. To approve the time, date, venue, mode and notice of the Extraordinary General Meeting (EGM) of shareholders to obtain their consent for necessary resolutions. 3. To appoint a scrutinizer to oversee the voting process at the EGM. 4. To take on record the necessary certificates and reports from the Statutory Auditors and Practicing Company Secretary related to the aforementioned matters. 5. To discuss any other matters with the permission of the Chair
06 Nov 202409 Nov 2024 Quarterly Results
06 Aug 202414 Aug 2024 Quarterly Results
13 May 202418 May 2024 Audited Results
24 Jan 202431 Jan 2024 Quarterly Results
16 Jan 202424 Jan 2024 Issue Of Warrants & Preferential Issue of shares & Rights Issue
31 Oct 202309 Nov 2023 Quarterly Results
02 Aug 202310 Aug 2023 Quarterly Results
10 Jul 202318 Jul 2023 Right Issue of Equity Shares
03 Jul 202311 Jul 2023 Right Issue of Equity Shares
23 May 202329 May 2023 Audited Results
03 Feb 202314 Feb 2023 Quarterly Results
19 Jan 202325 Jan 2023 Right Issue of Equity Shares
07 Nov 202214 Nov 2022 Quarterly Results
03 Aug 202210 Aug 2022 Quarterly Results
Page 1 of 4
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.